Skip to content
CNS Clinical Research

Wisconsin

CNS clinical trials in Wisconsin

46 CNS studies are recruiting participants at sites in 39 cities across Wisconsin as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Wisconsin city with a recruiting study

By research area: Depression (14), Multiple Sclerosis (12), Migraine (8), Parkinson's Disease (7), ADHD (2), Epilepsy (2), Schizophrenia (1).

Milwaukee (23), Madison (18), Kenosha (4), Eau Claire (2), Greenfield (2), Neenah (2), Waukesha (2), Antigo (1), Appleton (1), Berlin (1), Burlington (1), Cudahy (1), Delafield (1), Germantown (1), Grafton (1), Green Bay (1), La Crosse (1), Marinette (1), Marshfield (1), Medford (1), Mequon (1), Mukwonago (1), New London (1), Oconomowoc (1), Oconto Falls (1), Oshkosh (1), Racine (1), Rhinelander (1), Shawano (1), Sheboygan (1), Stevens Point (1), Sturgeon Bay (1), Summit (1), Two Rivers (1), Waupaca (1), Wausau (1), Wauwatosa (1), West Allis (1), Wisconsin Rapids (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Wisconsin

Basic details from each study's public record (the 12 most recently updated of 46). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    • Phase 2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Reunion Neuroscience Inc
    Recruiting in
    Madison
    Registry record
    NCT07002034 · updated
  2. A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    LivaNova
    Recruiting in
    Madison
    Registry record
    NCT03887715 · updated
  3. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Antigo · Appleton · Berlin · and 31 more U.S. locations
    Registry record
    NCT06748222 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Wisconsin on ClinicalTrials.gov.

Parkinson's disease: recently updated in Wisconsin

  1. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Recruiting in
    Madison
    Registry record
    NCT06989112 · updated
  2. A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Madison
    Registry record
    NCT06345729 · updated
  3. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Madison
    Registry record
    NCT06966700 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Wisconsin on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Wisconsin

  1. A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    Milwaukee
    Registry record
    NCT07067463 · updated
  2. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    TG Therapeutics, Inc.
    Recruiting in
    Greenfield · Milwaukee · Neenah · and 1 more U.S. location
    Registry record
    NCT06433752 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Wisconsin on ClinicalTrials.gov.

Epilepsy: recently updated in Wisconsin

  1. Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Neurona Therapeutics
    Recruiting in
    Milwaukee
    Registry record
    NCT05135091 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Wisconsin on ClinicalTrials.gov.

Migraine: recently updated in Wisconsin

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Recruiting in
    Marshfield · Milwaukee
    Registry record
    NCT06972056 · updated
  2. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Kenosha
    Registry record
    NCT07645924 · updated
  3. A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Kenosha
    Registry record
    NCT07674654 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Wisconsin on ClinicalTrials.gov.

Ask about studies in Wisconsin

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call